Keyword: J. Michael Pearson
News
23.03.2016
- J. Michael Pearson has stepped down as CEO of Canada-based Valeant Pharmaceuticals two months after returning from a medical leave, as the company’s stock continues to bleed. One...
News
24.08.2015
- US specialty drugs company Valeant Pharmaceuticals has agreed to pay $1 billion in cash, on a debt-free basis, for female sexual heath firm Sprout Pharmaceuticals. Under the terms...
